As of 2024-12-12, the Relative Valuation of Aelis Farma SA (AELIS.PA) is (3.33) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 2.70 EUR, the upside of Aelis Farma SA based on Relative Valuation is -223.4%.
The range of the Relative Valuation is (2.62) - (4.04) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.1x - 7.9x | 6.5x |
| Forward P/E multiples | 5.1x - 7.9x | 6.5x |
| Fair Price | (2.62) - (4.04) | (3.33) |
| Upside | -197.2% - -249.6% | -223.4% |
| Date | P/E |
| 2024-11-29 | -5.27 |
| 2024-11-28 | -5.27 |
| 2024-11-27 | -5.66 |
| 2024-11-26 | -5.58 |
| 2024-11-25 | -5.58 |
| 2024-11-22 | -5.62 |
| 2024-11-21 | -5.50 |
| 2024-11-20 | -5.77 |
| 2024-11-19 | -5.46 |
| 2024-11-18 | -5.74 |
| 2024-11-15 | -5.85 |
| 2024-11-14 | -5.85 |
| 2024-11-13 | -5.81 |
| 2024-11-12 | -5.81 |
| 2024-11-11 | -5.81 |
| 2024-11-08 | -5.97 |
| 2024-11-07 | -6.01 |
| 2024-11-06 | -6.48 |
| 2024-11-05 | -6.63 |
| 2024-11-04 | -6.79 |
| 2024-11-01 | -6.79 |
| 2024-10-31 | -6.79 |
| 2024-10-30 | -6.79 |
| 2024-10-29 | -6.71 |
| 2024-10-28 | -7.02 |
| 2024-10-25 | -7.02 |
| 2024-10-24 | -6.94 |
| 2024-10-23 | -6.87 |
| 2024-10-22 | -6.87 |
| 2024-10-21 | -7.26 |
| 2024-10-18 | -7.02 |
| 2024-10-17 | -7.69 |
| 2024-10-16 | -7.73 |
| 2024-10-15 | -7.73 |
| 2024-10-14 | -7.61 |
| 2024-10-11 | -7.61 |
| 2024-10-10 | -7.61 |
| 2024-10-09 | -7.57 |
| 2024-10-08 | -7.96 |
| 2024-10-07 | -8.04 |
| 2024-10-04 | -8.04 |
| 2024-10-03 | -8.08 |
| 2024-10-02 | -8.15 |
| 2024-10-01 | -8.39 |
| 2024-09-30 | -8.39 |
| 2024-09-27 | -8.86 |
| 2024-09-26 | -9.13 |
| 2024-09-25 | -9.33 |
| 2024-09-24 | -10.14 |
| 2024-09-23 | -10.14 |